Clinical Trial Update: Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium [Phase 3]

View source ↗

Summary

Phase 3 trial by Bayer evaluated the efficacy and safety of extended-release naproxen sodium for postoperative pain; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Naproxen sodium (extended-release) (naproxen sodium)

Snippet

Sponsor: Bayer | Conditions: Pain, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2013-05-07